Candida parapsilosis Cell Wall Proteome Characterization and Effectiveness against Hematogenously Disseminated

Xiaolong Gong1, Vartika Srivastava1, Previn Naicker2

  • 1Clinical Microbiology and Infectious Diseases, School of Pathology, Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa.

Vaccines
|March 30, 2023
PubMed

Insights

This study identified key cell wall proteins from Candida parapsilosis that show protective effects against infection in mice. These findings support the development of new vaccines and diagnostic tools for this challenging fungal pathogen.

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Candida parapsilosis causes significant clinical challenges, particularly in South Africa, affecting immunocompromised individuals and neonates.
  • Fungal cell wall proteins are crucial for pathogenesis, mediating interactions with the host and immune system.

Purpose of the Study:

  • To characterize immunodominant cell wall proteins of pathogenic Candida parapsilosis.
  • To evaluate the protective potential of these proteins in a murine model for vaccine development.

Main Methods:

  • Selected the most pathogenic and multidrug-resistant C. parapsilosis strains.
  • Extracted cell wall antigens using a β-mercaptoethanol/ammonium bicarbonate method.
  • Identified antigenic proteins via LC-MS/MS and assessed immunogenicity in BALB/c mice.

Main Results:

  • Identified 933 proteins, with 34 designated as immunodominant.
  • Immunized mice with cell wall protein extracts showed increased survival rates.
  • Vaccinated mice exhibited a reduced fungal burden in vital organs post-challenge.

Conclusions:

  • Cell wall-associated proteins of C. parapsilosis possess immunogenic properties.
  • These proteins show potential as biomarkers for developing diagnostic assays.
  • The identified proteins could be valuable for creating novel vaccines against C. parapsilosis infections.